It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Label warnings advised for flu drugs
WASHINGTON // Government health regulators are recommending adding label precautions about neurological problems seen in children who have taken flu drugs made by Roche and GlaxoSmithKline. The Food and Drug Administration released its safety review of Roche's Tamiflu and Glaxo's Relenza yesterday.
The FDA began reviewing Tamiflu's safety in 2005 after receiving reports of children experiencing neurological problems, including hallucinations and convulsions.
It's important to consider prevention and treatment strategies that can protect your children and your family.
You can help prevent and treat the flu in your children aged 1 year and older with TAMIFLU, the number 1 doctor-prescribed antiviral flu medicine*. TAMIFLU treats flu at its source by attacking the virus that causes the flu. It works by helping to stop the spread of the flu virus inside the body. TAMIFLU is available in a convenient liquid that's easy for children to swallow.
What's really interesting here is the vaccine called, TAMIFLU, oseltamivir phosphate, made by Roche. When examining one of the active ingredients, we find 1-cyclohexane-1. Strange because cyclohexane is considered a highly toxic substance. It's really funny but oh yes, cyclohexane is the chief ingredient in PCP commonly known as phenecyclidine, or maybe you've heard it as, all, yes again, Angel Dust!